ArticleTranslational lung cancer research2026
Real-world outcomes of consolidative durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer: the prognostic role of clinical frailty in the post-PACIFIC era.
Yoo-Kang Kwak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.